ARTICLES, APP NOTES, CASE STUDIES, & WHITE PAPERS

• Real-World Evidence - Where Are We Now?

  Notwithstanding ongoing confusion over the concepts of “real-world data” and “real-world evidence” in 2022, more than 5 years after the passage of the 21st Century Cures Act, the FDA continues to evaluate such data and evidence as it considers regulatory decisions.

• Why Are Study Builds The Same As Decades Ago?

  It seems that we as an industry have held onto a technology mindset that is no longer serving our needs. It’s time to move to a better way. Read our blog on the disconnect between clinical trial technology and legacy habits.

• Navigating The Next Wave Of Innovation In eCOA

  Learn how the right eCOA system enables site efficiency and elevated data quality, ensuring trials run smoothly and deliver more reliable results.

• Why eCOA Data Reporting Often Falls Short (And What To Do About It)

  By nature, eCOA and ePRO solutions are designed so it’s easy for clinicians and patients to provide clinical trial information. But this is only part of the equation. Discover how eCOA and ePRO solutions also need a thoughtful back-end experience. 

• The Benefits Of Real-Time ePRO/eCOA In Clinical Trials

  TrialKit addresses data management issues in clinical trials through its innovative ePRO and eCOA tools, which facilitate real-time data collection and reporting.

• 3 Key Functions Your eTMF Needs To Meet New EMA Regulations

  The European Union Clinical Trial Regulation No. 536/2014 recently introduced the most significant changes to the processes for clinical trial applications in at least the past 15 years. Learn how this impacts the Trial Master File and consider three key functions that an electronic TMF must have to achieve compliance and maintain organizational success.

• Data-Driven Adaptive Trials Enhance Safety, Progress, And Economics

  By offering guidance on optimizing ROI from extensive data collections and various endpoints in clinical studies, learn how IRT technology can enhance the data-driven approach for sponsors.

• Why eConsent Makes Such A Difference In Patient Adherence And Engagement

  Explore how consent is a critical step that can greatly influence patient enrollment, adherence and retention in the trial.

• Key To A Faster, More Flexible Clinical Trial Process

  Discover how a single, integrated data analytics and visualization platform, supported by an experienced partner, can help you move your investigational product to market more quickly.

• Overcoming 5 Challenges Of Implementing eClinical Technologies

  Assess five common pitfalls trial teams face when incorporating new technology and identify potential solutions to mitigate the common risks.